study start

study start

The formal recognition of the beginning of a clinical trial, which is referred to in the study report.
References in periodicals archive ?
SMClinical provides sponsor organizations with expert knowledge and guidance within three main business processes, Study Start Up (SSU), Trial Master File Management (TMF) and Risk Based Monitoring (RBM).
The investigators observed, after eight weeks of treatment, significant reductions occurred from the study start in the women's average daily hot flashes, the study's primary endpoint.
5 All sensitive to Kaletra at study start PIs used 0 31 NRTIs used 9 30 All who already used only 0 or 1 PI PIs used 0 28 NRTIs used 6 28 Note: Table made from bar graph.
The study included all children deprived of parental care residing in Belgrade, Serbia, 12 to 17 years old and living in out-of-home care for at least one year prior to study start.
Look closely, however, and you'll see this study start to come apart like a bad suture.
Beyond WCCT Global's patient recruitment strategy, the California CRO takes pride in offering the industry an expedited approach to study start up and enrollment.
The periods under study start with the Tudor and Jacobean, Baroque, early and late Georgian, colonial, Regency, Federal and Empire, Victorian, Arts and Crafts, Art Nouveau, Beaux Arts, the Modern movements and an expanded section on the contemporary era.
Removing some of the organizational and integration headaches from a study start obviously helps sponsors meet their timelines and stay within budget.
The SPA process was a bit slower than we would have liked, but we have been able to use the time productively to progress Institutional Review Board reviews and approvals, complete training and pre-study preparations of clinical site staff and central laboratories, and generally to limber up for a successful study start and race to complete patient recruitment.
SAIK-MS Phase II study indicates that laquinimod has the potential to become the first oral pharmaceutical developed specifically for the treatment of multiple sclerosis * Final result of the laquinimod (SAIK-MS) Phase II study confirms that the primary endpoint of the study has been reached * Extended analysis using independent statistical methods confirms the previously reported result: - Treatment with laquinimod yields 28 to 44% reduction in new inflammatory lesions in the brain after 24 weeks of treatment - Patients with active disease at study start responded more favourably to treatment with laquinimod, a 52% reduction in inflammatory lesions * The final analysis confirms the favourable safety profile of laquinimod .
Franklin's study starts in 1500, a choice based on comments by Giovio and Vasari, as well as formal observations.
The study starts with a theoretical briefing of the relationship between the autobiography and the literary letter.
Full browser ?